Financials

News Discussions Technicals Seasonals

CANTA_BTA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment. It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and pancreatic cancer. The company was founded by Thoas Michael Fioretos, Kjell Torsten Sjostrom, and Marcus Jaras on October 26, 2009 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CANTA_BTA does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company